Blocking a protein called PD-1 (programmed death 1) might provide a way to boost the function of T cells crippled by HIV, according to two studies published online in Nature and Nature Medicine.
Earlier this year, a study showed that blocking the function of PD-1 in virally infected mice could restore the function of ailing T cells and help fight infection.
In the paper published in Nature, Bruce Walker and his colleagues have now examined seventy one chronically infected HIV patients and found that their T cells have dramatically more PD-1 receptors on their surface, and that the degree of PD-1 production correlates with markers of disease progression including the extent to which T cells are disabled and the levels of virus within the body.
In the Nature Medicine study, Rafick-Pierre Sekaly and his colleagues find similar correlations in nineteen HIV infected patients and show that, over time, fluctuations in HIV load mirror levels of PD-1 expression on the T cells.
Notably, both groups of researchers find that an antibody that blocks this receptor promotes the immune response to HIV in laboratory experiments, raising hope that a similar strategy might work to fight the disease in humans.
Bruce Walker (Partners AIDS Research Center, Boston, MA, USA)
Nature Medicine paper
Rafick-Pierre Sekaly (Centre de Recherche du CHUM, Montreal, Canada)
(C) Nature press release.
(C) Nature Medicine press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking